Finnegan Henderson Farabow Garrett & Dunner

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the world’s largest full-service IP firms. With offices in the United States, Asia and Europe, the firm practices European, German, UK, and U.S. IP law. In addition to services related to all aspects of patent, trademark, and copyright law, including counseling, prosecution, licensing, and litigation, Finnegan provides counseling and litigation services in advertising, privacy, and a wide spectrum of additional IP-adjacent commercial matters, including trade secrets, international trade, the Internet, e-commerce, government contracts, antitrust, and unfair competition. A comprehensive approach to clients’ IP needs and Finnegan’s mega-boutique size underpins its year-to-year, decade-to-decade preeminence in IP litigation across all industries and tribunals.

Finnegan offers full-service IP legal and technical experience in virtually every industry and technology: biotechnology, pharmaceuticals, biologics and biosimilars, combination products, chemicals, electronics, semiconductors, computers and software, FinTech, blockchain, Internet of Things (IoT), automotive, aerospace and aviation, industrial manufacturing, consumer products, food and beverage, outdoor recreation, sports and fitness, digital health, medical devices, clean energy and renewables, robotics, textiles, artificial intelligence (AI) and machine learning (ML), and 3D printing.

With Finnegan’s practice centered on intellectual property, the firm is able to create economies of scale and focus all resources on providing the best tools and teams for clients. The firm’s team is comprised of over 250 litigators, including career trial attorneys. Over 300 of Finnegan’s legal professionals hold degrees in scientific disciplines (60+ hold PhDs). Over 225 professionals are registered to practise before the US Patent and Trademark Office (USPTO), European Patent Office (EPO), the German Patent and Trade Mark Office (DPMA), the UK Intellectual Property Office (UKIPO), and the European Union Intellectual Property Office (EUIPO). With more than 55 years’ IP experience, Finnegan handles hundreds of cases and proceedings across IP-related venues, including district courts, the US International Trade Commission (ITC), the USPTO’s Patent Trial and Appeal Board (PTAB), US Court of Appeals for the Federal Circuit and the US Supreme Court. As one of the first firms to file a petition and subsequently argue a post-grant review of a covered business method case following the implementation of the America Invents Act, Finnegan is one of the busiest law firms representing petitioners and patent owners in post-grant review proceedings. The firm files approximately 2,500 US and 1,000 foreign patent applications annually.

Surveys conducted by legal and business publications consistently rank Finnegan as one of the leading IP law practices in the world. The firm is ranked in the United States for contentious and prosecution patent and trademark work by publications including Managing Intellectual Property and The Legal 500, which have ranked Finnegan as a top-tier firm in nearly every significant IP category for over 10 years. The publications cite the firm’s winning record, technical expertise and deep bench of talent in all aspects of IP litigation, including trials, appeals and proceedings at the USPTO and ITC investigations.

Representative engagements:

• Represented Maglula Ltd. in a one-of-a-kind district court litigation including patent, trademark, and copyright claims over Maglula’s assertions that Amazon sold counterfeit consumer products. After the court issued an order denying Amazon’s motion for summary judgment, the parties entered into an agreement and the case was dismissed.
• Achieved a complete win for AstraZeneca in a Hatch-Waxman litigation involving patents protecting FARXIGA®, one of AstraZeneca’s billion-dollar-a-year drugs used for the treatment of diabetes.
• Achieved a clean sweep victory for client Playtika, invalidating all five of its adversary’s gaming patents in district court litigation. The victory included challenging the asserted patents in IPR proceedings before the PTAB.
• Represented BMW of North America, LLC and Bayerische Motoren Werke AG (collectively, “BMW”) before the ITC, which, in a final determination, terminated an investigation brought on by a semiconductor patent holder attempting to ban the importation and sale of several hybrid and electric BMW vehicles into the United States.
• Handles high volume U.S. patent and trademark prosecution, global IP portfolio development and management, brand protection, and counseling to protect e-commerce giant Coupang’s global IP interests.